시장보고서
상품코드
1711609

핵의학 및 방사성 의약품 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 최종 사용자, 형태, 재료 유형, 프로세스, 장비

Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Form, Material Type, Process, Equipment

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 352 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

핵의학 및 방사성 의약품 시장은 2024년의 48억 달러에서 2034년까지는 126억 달러로 성장할 전망이며 약 10.1%의 연평균 성장률(CAGR)을 나타낼 것으로 예측되고 있습니다. 이 시장은 진단 및 치료를 위한 방사성 물질의 생산과 응용을 포함합니다. 여기에는 PET 및 SPECT와 같은 이미징 기술과 종양학 및 심장학에서의 치료적 용도가 포함됩니다.

시장 개요

핵의학 및 방사성 의약품 시장은 다양한 부문으로 구성되어 있으며, 진단용 방사성의약품이 질병 조기 발견 및 관리에서 중추적인 역할을 담당하여 시장을 주도하고 있습니다. 이 부문의 지배력은 암 및 심혈관 질환과 같은 만성 질환의 유병률 증가와 PET 및 SPECT와 같은 이미징 기술의 발전에 힘입은 바가 큽니다. 치료용 방사성 의약품은 특히 표적 방사성 동위원소 치료법이 부작용을 최소화하면서 유망한 치료 방법을 제공하는 종양학 분야에서 빠르게 주목을 받고 있습니다. 떠오르는 하위 분야 중 테라노스틱스는 진단 및 치료 기능을 통합하여 개인 맞춤형 치료 전략을 제공함으로써 시장에 혁명을 일으킬 것입니다. 또한 신경학, 특히 알츠하이머 및 파킨슨병 연구에서 방사성 의약품의 적용이 증가함에 따라 시장에 큰 영향을 미칠 수 있는 잠재력을 보여주고 있습니다. 방사성 동위원소 생산의 지속적인 혁신과 새로운 방사성 의약품에 대한 규제 지원은 시장 성장을 더욱 강화하여 이해관계자들에게 수익성 높은 기회를 약속합니다.

시장 세분화
유형 진단용 방사성 의약품, 치료용 방사성 의약품
제품 테크네튬-99m, 요오드-131, 불소1-8, 루테튬-177, 이트륨-90, 갈륨-68, 라듐-223
서비스 방사성 동위원소 제조, 방사성 약학 서비스, 핵의학 이미징 서비스
기술 단일 광자 방출 컴퓨터 단층 촬영법(SPECT), 양전자 방출 단층 촬영법(PET), 하이브리드 이미징
용도 종양학, 심장학, 신경학, 내분비학, 소화기 내과, 감염증학, 신장학
최종 사용자 병원, 진단 영상 센터, 학술 및 연구 기관
형태 액체, 캡슐
재료 유형 유기 화합물, 무기 화합물
제조 공정 사이클로트론 제조, 원자로 제조
장비 감마 카메라, PET 스캐너, SPECT 스캐너

핵의학 및 방사성의약품 시장에서 진단용 방사성의약품은 만성 질환의 유병률 증가와 조기 정밀 진단 기술에 대한 수요 증가에 힘입어 두드러진 점유율을 차지하고 있습니다. 표적 암 치료와 개인 맞춤형 의학 접근법의 발전을 반영하여 치료용 방사성의약품도 주목을 받고 있습니다. 북미는 탄탄한 의료 인프라와 활발한 연구 활동으로 시장을 선도하고 있으며, 아시아태평양 지역은 의료 투자 확대와 핵의학 응용 분야에 대한 인식 상승에 힘입어 빠르게 성장하고 있습니다.

경쟁 구도은 Siemens Healthineers, GE Healthcare, Cardinal Health 등 주요 업체들의 존재로 특징지어집니다. 특히 미국과 유럽의 규제 환경은 점점 더 엄격해지고 있어 엄격한 안전 및 효능 기준을 준수해야 합니다. 앞으로 방사성 의약품 생산 기술의 발전과 종양학 및 심장학 분야의 핵의학 응용 분야 확대에 힘입어 시장은 크게 성장할 것으로 전망됩니다. 그러나 신흥 시장과 새로운 치료 응용 분야에서 발생하는 상당한 성장 기회에도 불구하고 높은 개발 비용 및 규제 승인 절차와 같은 과제가 남아 있습니다.

주요 동향 및 촉진요인

핵의학 및 방사성 의약품 시장은 이미징 기술의 발전과 만성 질환의 유병률 증가에 힘입어 견고한 성장세를 보이고 있습니다. 주요 트렌드에는 이미징 솔루션에 인공 지능을 통합하여 진단 정확도와 효율성을 높이는 것이 포함됩니다. 특정 질병을 표적으로 하는 새로운 방사성 의약품의 개발도 주목받고 있으며, 개인 맞춤형 치료 옵션과 개선된 환자 치료 결과를 제공합니다.

비침습적 진단 기술에 대한 수요 증가와 만성 질환에 더 취약한 노인 인구의 증가도 시장 성장을 촉진하는 요인입니다. 또한 암 연구와 핵의학을 장려하는 정부 노력이 시장 확대를 촉진하고 있습니다.

미개척 시장, 특히 의료 인프라가 발전하고 있는 개발도상국에서 새로운 기회가 생겨나고 있습니다. 혁신적이고 비용 효율적인 방사성 의약품을 개발하기 위해 연구 개발에 투자하는 기업은 시장 점유율을 확보할 수 있는 유리한 위치에 있습니다. 또한, 학술 기관과 업계 종사자 간의 협력은 핵의학 분야의 발전을 촉진하여 이 분야의 미래 성장과 혁신을 위한 토대를 마련하고 있습니다

억제요인 및 도전과제

핵의학 및 방사성 의약품 시장에는 몇 가지 중요한 억제요인과 도전에 직면해 있습니다. 첫째, 엄격한 규제 요건이 상당한 도전 과제입니다. 새로운 방사성의약품의 승인 절차는 복잡하고 시간이 오래 걸리기 때문에 시장 진입이 지연되는 경우가 많습니다. 또한 방사성 의약품의 높은 생산 비용으로 인해 특히 개발도상국에서는 접근성과 경제성이 제한됩니다. 또 다른 문제는 숙련된 전문가가 부족하다는 점입니다. 이러한 물질을 취급하고 관리하는 데 필요한 전문 지식이 부족하여 서비스 제공에 영향을 미칩니다. 또한 방사성 의약품의 짧은 반감기를 비롯한 공급망의 복잡성으로 인해 효율적인 물류가 필요한데, 이를 유지하기가 어려울 수 있습니다. 마지막으로 방사선 피폭에 대한 대중의 인식과 안전 우려는 안전 프로토콜의 발전에도 불구하고 시장 수용을 저해합니다. 이러한 문제들은 핵의학 및 방사성의약품의 성장과 광범위한 채택을 총체적으로 방해하고 있습니다.

목차

제1장 핵의학 및 방사성 의약품 시장 개요

  • 조사 목적
  • 핵의학 및 방사성 의약품 시장 정의 및 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 연도 및 통합
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 핵의학 및 방사성 의약품 시장 전망

  • 핵의학 및 방사성 의약품 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 핵의학 및 방사성 의약품 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 핵의학 및 방사성 의약품 시장 규모

  • 핵의학 및 방사성 의약품 시장 규모 : 금액별
  • 핵의학 및 방사성 의약품 시장 규모 : 수량별

제7장 핵의학 및 방사성 의약품 시장 : 유형별

  • 시장 개요
  • 진단용 방사성 의약품
  • 치료용 방사성 의약품
  • 기타

제8장 핵의학 및 방사성 의약품 시장 : 제품별

  • 시장 개요
  • 테크네튬-99m
  • 요오드-131
  • 불소-18
  • 루테튬-177
  • 이트륨-90
  • 갈륨-68
  • 라듐-223
  • 기타

제9장 핵의학 및 방사성 의약품 시장 : 서비스별

  • 시장 개요
  • 방사성 동위 원소 제조
  • 방사성 약학 서비스
  • 핵의학 이미징 서비스
  • 기타

제10장 핵의학 및 방사성 의약품 시장 : 기술별

  • 시장 개요
  • 단일 광자 방출 컴퓨터 단층 촬영법(SPECT)
  • 양전자 방출 단층 촬영법(PET)
  • 하이브리드 이미징
  • 기타

제11장 핵의학 및 방사성 의약품 시장 : 용도별

  • 시장 개요
  • 종양학
  • 심장학
  • 신경학
  • 내분비학
  • 소화기 내과
  • 감염증학
  • 신장학
  • 기타 종양학, 심장학, 신경학, 내분비학, 소화기 내과, 감염증학, 신장학

제12장 핵의학 및 방사성 의약품 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 진단 영상 센터
  • 학술기관 및 연구기관
  • 기타

제13장 핵의학 및 방사성 의약품 시장 : 형태별

  • 시장 개요
  • 액체
  • 캡슐
  • 기타

제14장 핵의학 및 방사성 의약품 시장 : 재료 유형별

  • 시장 개요
  • 유기 화합물
  • 무기 화합물
  • 기타

제15장 핵의학 및 방사성 의약품 시장 : 프로세스별

  • 시장 개요
  • 사이클로트론 제조
  • 원자로 제조
  • 기타

제16장 핵의학 및 방사성 의약품 시장 : 장비별

  • 시장 개요
  • 감마 카메라
  • PET 스캐너
  • SPECT 스캐너
  • 기타

제17장 핵의학 및 방사성 의약품 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제19장 기업 프로파일

  • Advanced Accelerator Applications
  • Jubilant Radiopharma
  • Curium Pharma
  • NorthStar Medical Radioisotopes
  • Shine Medical Technologies
  • Isotopia Molecular Imaging
  • ITM Isotopen Technologien Munchen
  • Eckert & Ziegler
  • Nordion
  • RadioMedix
  • Cyclopharm
  • Clarity Pharmaceuticals
  • Blue Earth Diagnostics
  • Progenics Pharmaceuticals
  • Navidea Biopharmaceuticals
  • Lantheus Holdings
  • Sofie Biosciences
  • Radiopharm Theranostics
  • Telix Pharmaceuticals
  • Cardinal Health Nuclear Pharmacy Services
HBR 25.05.22

Nuclear Medicine/Radiopharmaceuticals Market is anticipated to expand from $4.8 billion in 2024 to $12.6 billion by 2034, growing at a CAGR of approximately 10.1%. The market encompasses the production and application of radioactive substances for diagnosis and therapy. It involves imaging techniques like PET and SPECT, and therapeutic uses in oncology and cardiology. This market is driven by advancements in molecular imaging, increasing cancer prevalence, and a rising demand for non-invasive procedures, highlighting opportunities for innovation in targeted radiopharmaceuticals.

Market Overview

The Nuclear Medicine/Radiopharmaceuticals Market is characterized by a diverse array of segments, with diagnostic radiopharmaceuticals leading the charge, primarily due to their pivotal role in early disease detection and management. This segment's dominance is driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, coupled with advancements in imaging technologies like PET and SPECT. Therapeutic radiopharmaceuticals are rapidly gaining traction, particularly in oncology, where targeted radioisotope therapies offer promising treatment avenues with minimal side effects. Among emerging sub-segments, theranostics is poised to revolutionize the market by integrating diagnostic and therapeutic capabilities, providing personalized treatment strategies. Furthermore, the increasing application of radiopharmaceuticals in neurology, especially in Alzheimer's and Parkinson's disease research, underscores the potential for significant market impact. Continuous innovation in radioisotope production and regulatory support for novel radiopharmaceuticals further bolsters market growth, promising lucrative opportunities for stakeholders.

Market Segmentation
TypeDiagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals
ProductTechnetium-99m, Iodine-131, Fluorine-18, Lutetium-177, Yttrium-90, Gallium-68, Radium-223
ServicesRadioisotope Production, Radiopharmacy Services, Nuclear Imaging Services
TechnologySingle Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Hybrid Imaging
ApplicationOncology, Cardiology, Neurology, Endocrinology, Gastroenterology, Infectious Diseases, Nephrology
End UserHospitals, Diagnostic Imaging Centers, Academic and Research Institutes
FormLiquid, Capsule
Material TypeOrganic Compounds, Inorganic Compounds
ProcessCyclotron Production, Nuclear Reactor Production
EquipmentGamma Cameras, PET Scanners, SPECT Scanners

In the nuclear medicine and radiopharmaceuticals market, diagnostic radiopharmaceuticals hold a prominent share, driven by the increasing prevalence of chronic diseases and the rising demand for early and precise diagnostic techniques. Therapeutic radiopharmaceuticals are gaining traction as well, reflecting advancements in targeted cancer therapies and personalized medicine approaches. North America leads the market due to its robust healthcare infrastructure and significant research activities, while the Asia-Pacific region is witnessing rapid growth fueled by expanding healthcare investments and rising awareness of nuclear medicine applications.

The competitive landscape is marked by the presence of key players such as Siemens Healthineers, GE Healthcare, and Cardinal Health, which are actively engaged in strategic collaborations and technological innovations to enhance their market position. Regulatory environments, particularly in the United States and Europe, are becoming increasingly stringent, necessitating compliance with rigorous safety and efficacy standards. Looking ahead, the market is poised for substantial growth, driven by advancements in radiopharmaceutical production technologies and the expansion of nuclear medicine applications in oncology and cardiology. However, challenges such as high costs of development and regulatory approval processes remain, albeit with significant opportunities for growth arising from emerging markets and novel therapeutic applications.

Recent Developments:

The Nuclear Medicine/Radiopharmaceuticals Market has experienced noteworthy developments over the past three months. GE HealthCare announced a strategic partnership with NorthStar Medical Radioisotopes to advance the production of diagnostic and therapeutic radiopharmaceuticals, enhancing supply chain reliability and expanding product offerings. In a significant merger and acquisition move, Curium acquired IASON, a European leader in PET radiopharmaceuticals, to strengthen its position in the European market and broaden its product portfolio. Cardinal Health unveiled a new state-of-the-art radiopharmacy in the United States, aiming to improve the distribution efficiency of nuclear medicine products and meet the growing demand for radiopharmaceuticals. The European Medicines Agency approved a new radiopharmaceutical therapy developed by Telix Pharmaceuticals, marking a milestone for the company and expanding treatment options for prostate cancer. Lastly, Siemens Healthineers announced a collaboration with the University of Pennsylvania to develop innovative imaging technologies, focusing on enhancing the precision of nuclear medicine diagnostics. These developments underscore the sector's dynamic growth and the strategic maneuvers by key players to capitalize on emerging opportunities.

Key Trends and Drivers:

The nuclear medicine and radiopharmaceuticals market is experiencing robust growth, propelled by advancements in diagnostic imaging technologies and increasing prevalence of chronic diseases. Key trends include the integration of artificial intelligence in imaging solutions, enhancing diagnostic accuracy and efficiency. The development of novel radiopharmaceuticals targeting specific diseases is also gaining traction, offering personalized treatment options and improved patient outcomes.

Drivers of the market encompass the rising demand for non-invasive diagnostic techniques and the growing geriatric population, which is more susceptible to chronic conditions. Additionally, government initiatives promoting cancer research and nuclear medicine are bolstering market expansion. The increasing adoption of hybrid imaging systems, such as PET/CT and SPECT/CT, is further driving growth by providing comprehensive diagnostic insights.

Opportunities are emerging in untapped markets, particularly in developing regions where healthcare infrastructure is evolving. Companies investing in research and development to create innovative, cost-effective radiopharmaceuticals are well-positioned to capture market share. Furthermore, collaborations between academic institutions and industry players are fostering advancements in nuclear medicine, paving the way for future growth and innovation in the sector.

Restraints and Challenges:

The Nuclear Medicine/Radiopharmaceuticals Market encounters several significant restraints and challenges. Firstly, stringent regulatory requirements pose a substantial challenge. The approval process for new radiopharmaceuticals is complex and time-consuming, often delaying market entry. Additionally, high production costs for radiopharmaceuticals limit their accessibility and affordability, particularly in developing regions. Another challenge is the shortage of skilled professionals. The specialized knowledge required to handle and administer these substances is scarce, impacting service delivery. Furthermore, supply chain complexities, including the short half-life of radiopharmaceuticals, necessitate efficient logistics, which can be difficult to maintain. Lastly, public perception and safety concerns about radiation exposure hinder market acceptance, despite advancements in safety protocols. These challenges collectively impede the growth and broader adoption of nuclear medicine and radiopharmaceuticals.

Key Companies:

Advanced Accelerator Applications, Jubilant Radiopharma, Curium Pharma, North Star Medical Radioisotopes, Shine Medical Technologies, Isotopia Molecular Imaging, ITM Isotopen Technologien Munchen, Eckert & Ziegler, Nordion, Radio Medix, Cyclopharm, Clarity Pharmaceuticals, Blue Earth Diagnostics, Progenics Pharmaceuticals, Navidea Biopharmaceuticals, Lantheus Holdings, Sofie Biosciences, Radiopharm Theranostics, Telix Pharmaceuticals, Cardinal Health Nuclear Pharmacy Services

Sources:

World Nuclear Association, International Atomic Energy Agency (IAEA), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Society of Nuclear Medicine and Molecular Imaging (SNMMI), European Association of Nuclear Medicine (EANM), Radiological Society of North America (RSNA), American College of Radiology (ACR), National Institutes of Health (NIH), U.S. Department of Energy (DOE), Canadian Nuclear Safety Commission (CNSC), Australian Nuclear Science and Technology Organisation (ANSTO), Japan Atomic Energy Agency (JAEA), United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), International Conference on Radiopharmaceutical Sciences, World Congress of Nuclear Medicine and Biology, International Symposium on Radiopharmaceutical Chemistry, European Congress of Radiology, International Conference on Isotopes, International Atomic Energy Agency General Conference

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Nuclear Medicine/Radiopharmaceuticals Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Nuclear Medicine/Radiopharmaceuticals Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Form
  • 2.10 Key Highlights of the Market, by Material Type
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by Equipment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Form
  • 3.9 Market Attractiveness Analysis, by Material Type
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by Equipment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Nuclear Medicine/Radiopharmaceuticals Market Outlook

  • 4.1 Nuclear Medicine/Radiopharmaceuticals Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Nuclear Medicine/Radiopharmaceuticals Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Nuclear Medicine/Radiopharmaceuticals Market Size

  • 6.1 Nuclear Medicine/Radiopharmaceuticals Market Size, by Value
  • 6.2 Nuclear Medicine/Radiopharmaceuticals Market Size, by Volume

7: Nuclear Medicine/Radiopharmaceuticals Market, by Type

  • 7.1 Market Overview
  • 7.2 Diagnostic Radiopharmaceuticals
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Radiopharmaceuticals
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Nuclear Medicine/Radiopharmaceuticals Market, by Product

  • 8.1 Market Overview
  • 8.2 Technetium-99m
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Iodine-131
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fluorine-18
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Lutetium-177
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Yttrium-90
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Gallium-68
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Radium-223
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Nuclear Medicine/Radiopharmaceuticals Market, by Services

  • 9.1 Market Overview
  • 9.2 Radioisotope Production
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Radiopharmacy Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Nuclear Imaging Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Nuclear Medicine/Radiopharmaceuticals Market, by Technology

  • 10.1 Market Overview
  • 10.2 Single Photon Emission Computed Tomography (SPECT)
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Positron Emission Tomography (PET)
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Hybrid Imaging
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Nuclear Medicine/Radiopharmaceuticals Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cardiology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Neurology
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Endocrinology
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Gastroenterology
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Infectious Diseases
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Nephrology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Others
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region

12: Nuclear Medicine/Radiopharmaceuticals Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Diagnostic Imaging Centers
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Academic and Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Nuclear Medicine/Radiopharmaceuticals Market, by Form

  • 13.1 Market Overview
  • 13.2 Liquid
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Capsule
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Nuclear Medicine/Radiopharmaceuticals Market, by Material Type

  • 14.1 Market Overview
  • 14.2 Organic Compounds
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Inorganic Compounds
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Nuclear Medicine/Radiopharmaceuticals Market, by Process

  • 15.1 Market Overview
  • 15.2 Cyclotron Production
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Nuclear Reactor Production
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Nuclear Medicine/Radiopharmaceuticals Market, by Equipment

  • 16.1 Market Overview
  • 16.2 Gamma Cameras
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 PET Scanners
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 SPECT Scanners
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Nuclear Medicine/Radiopharmaceuticals Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Form
    • 17.2.9 North America Market Size and Forecast, by Material Type
    • 17.2.10 North America Market Size and Forecast, by Process
    • 17.2.11 North America Market Size and Forecast, by Equipment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Form
      • 17.2.9.8 United States Market Size and Forecast, by Material Type
      • 17.2.9.9 United States Market Size and Forecast, by Process
      • 17.2.9.10 United States Market Size and Forecast, by Equipment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Form
      • 17.2.10.8 Canada Market Size and Forecast, by Material Type
      • 17.2.10.9 Canada Market Size and Forecast, by Process
      • 17.2.10.10 Canada Market Size and Forecast, by Equipment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Form
    • 17.3.9 Europe Market Size and Forecast, by Material Type
    • 17.3.10 Europe Market Size and Forecast, by Process
    • 17.3.11 Europe Market Size and Forecast, by Equipment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Equipment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Form
      • 17.3.10.8 Germany Market Size and Forecast, by Material Type
      • 17.3.10.9 Germany Market Size and Forecast, by Process
      • 17.3.10.10 Germany Market Size and Forecast, by Equipment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Form
      • 17.3.11.8 France Market Size and Forecast, by Material Type
      • 17.3.11.9 France Market Size and Forecast, by Process
      • 17.3.11.10 France Market Size and Forecast, by Equipment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Form
      • 17.3.12.8 Spain Market Size and Forecast, by Material Type
      • 17.3.12.9 Spain Market Size and Forecast, by Process
      • 17.3.12.10 Spain Market Size and Forecast, by Equipment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Form
      • 17.3.13.8 Italy Market Size and Forecast, by Material Type
      • 17.3.13.9 Italy Market Size and Forecast, by Process
      • 17.3.13.10 Italy Market Size and Forecast, by Equipment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Form
      • 17.3.14.8 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.9 Netherlands Market Size and Forecast, by Process
      • 17.3.14.10 Netherlands Market Size and Forecast, by Equipment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Form
      • 17.3.15.8 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.9 Sweden Market Size and Forecast, by Process
      • 17.3.15.10 Sweden Market Size and Forecast, by Equipment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Form
      • 17.3.16.8 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.9 Switzerland Market Size and Forecast, by Process
      • 17.3.16.10 Switzerland Market Size and Forecast, by Equipment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Form
      • 17.3.17.8 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.9 Denmark Market Size and Forecast, by Process
      • 17.3.17.10 Denmark Market Size and Forecast, by Equipment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Form
      • 17.3.18.8 Finland Market Size and Forecast, by Material Type
      • 17.3.18.9 Finland Market Size and Forecast, by Process
      • 17.3.18.10 Finland Market Size and Forecast, by Equipment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Form
      • 17.3.19.8 Russia Market Size and Forecast, by Material Type
      • 17.3.19.9 Russia Market Size and Forecast, by Process
      • 17.3.19.10 Russia Market Size and Forecast, by Equipment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Equipment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Equipment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Form
      • 17.4.9.8 China Market Size and Forecast, by Material Type
      • 17.4.9.9 China Market Size and Forecast, by Process
      • 17.4.9.10 China Market Size and Forecast, by Equipment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Form
      • 17.4.10.8 India Market Size and Forecast, by Material Type
      • 17.4.10.9 India Market Size and Forecast, by Process
      • 17.4.10.10 India Market Size and Forecast, by Equipment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Form
      • 17.4.11.8 Japan Market Size and Forecast, by Material Type
      • 17.4.11.9 Japan Market Size and Forecast, by Process
      • 17.4.11.10 Japan Market Size and Forecast, by Equipment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Form
      • 17.4.12.8 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.9 South Korea Market Size and Forecast, by Process
      • 17.4.12.10 South Korea Market Size and Forecast, by Equipment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Form
      • 17.4.13.8 Australia Market Size and Forecast, by Material Type
      • 17.4.13.9 Australia Market Size and Forecast, by Process
      • 17.4.13.10 Australia Market Size and Forecast, by Equipment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Form
      • 17.4.14.8 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.9 Singapore Market Size and Forecast, by Process
      • 17.4.14.10 Singapore Market Size and Forecast, by Equipment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Form
      • 17.4.15.8 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.9 Indonesia Market Size and Forecast, by Process
      • 17.4.15.10 Indonesia Market Size and Forecast, by Equipment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Form
      • 17.4.16.8 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.9 Taiwan Market Size and Forecast, by Process
      • 17.4.16.10 Taiwan Market Size and Forecast, by Equipment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Form
      • 17.4.17.8 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.9 Malaysia Market Size and Forecast, by Process
      • 17.4.17.10 Malaysia Market Size and Forecast, by Equipment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Equipment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Form
    • 17.5.9 Latin America Market Size and Forecast, by Material Type
    • 17.5.10 Latin America Market Size and Forecast, by Process
    • 17.5.11 Latin America Market Size and Forecast, by Equipment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Form
      • 17.5.9.8 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.9 Brazil Market Size and Forecast, by Process
      • 17.5.9.10 Brazil Market Size and Forecast, by Equipment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Form
      • 17.5.10.8 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.9 Mexico Market Size and Forecast, by Process
      • 17.5.10.10 Mexico Market Size and Forecast, by Equipment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Form
      • 17.5.11.8 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.9 Argentina Market Size and Forecast, by Process
      • 17.5.11.10 Argentina Market Size and Forecast, by Equipment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Equipment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Equipment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Equipment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Form
      • 17.6.10.8 UAE Market Size and Forecast, by Material Type
      • 17.6.10.9 UAE Market Size and Forecast, by Process
      • 17.6.10.10 UAE Market Size and Forecast, by Equipment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Form
      • 17.6.11.8 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.9 South Africa Market Size and Forecast, by Process
      • 17.6.11.10 South Africa Market Size and Forecast, by Equipment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Equipment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Advanced Accelerator Applications
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Jubilant Radiopharma
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Curium Pharma
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 NorthStar Medical Radioisotopes
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Shine Medical Technologies
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Isotopia Molecular Imaging
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 ITM Isotopen Technologien Munchen
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Eckert & Ziegler
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Nordion
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 RadioMedix
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Cyclopharm
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Clarity Pharmaceuticals
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Blue Earth Diagnostics
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Progenics Pharmaceuticals
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Navidea Biopharmaceuticals
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Lantheus Holdings
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Sofie Biosciences
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Radiopharm Theranostics
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Telix Pharmaceuticals
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Cardinal Health Nuclear Pharmacy Services
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제